Cao Zhe, Oyang Linda, Luo Xia, Xia Longzheng, Hu Jiaqi, Lin Jinguan, Tan Shiming, Tang Yanyan, Zhou Yujuan, Cao Deliang, Liao Qianjin
Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
Clinical Research Center for Wound Healing in Hunan Province, Changsha 410013, Hunan, China.
J Cancer. 2022 Jan 1;13(1):174-183. doi: 10.7150/jca.65031. eCollection 2022.
Lung cancer is the most common malignancy, being a serious threat of human lives. The incidence and mortality of lung cancer has been increasing rapidly in the past decades. Although the development of new therapeutic modes, such as target therapy, the overall survival rate of lung cancer remains low. It is urgent to advance the understanding of molecular oncology and find novel biomarkers and targets for the early diagnosis, treatment, and prognostic prediction of lung cancer. Long non-coding RNAs (lncRNAs) are non-protein coding RNA transcripts that are more than 200 nucleotides in length. LncRNAs exert diverse biological functions by regulating gene expressions at transcriptional, translational, and post-translational levels. In the past decade, it has been shown that lncRNAs are extensively involved in the pathogenesis of various diseases, including lung cancer. In this review, we highlighted the lncRNAs characterized in lung cancer and discussed their translational potential in lung cancer clinics.
肺癌是最常见的恶性肿瘤,严重威胁人类生命。在过去几十年中,肺癌的发病率和死亡率一直在迅速上升。尽管出现了新的治疗模式,如靶向治疗,但肺癌的总体生存率仍然很低。迫切需要加深对分子肿瘤学的理解,并找到用于肺癌早期诊断、治疗和预后预测的新型生物标志物和靶点。长链非编码RNA(lncRNAs)是长度超过200个核苷酸的非蛋白质编码RNA转录本。lncRNAs通过在转录、翻译和翻译后水平调节基因表达发挥多种生物学功能。在过去十年中,已表明lncRNAs广泛参与包括肺癌在内的各种疾病的发病机制。在本综述中,我们重点介绍了在肺癌中已被鉴定的lncRNAs,并讨论了它们在肺癌临床中的转化潜力。